Nonclinical safety, toxicokinetic, and stability evaluation of bioresponse diindolylmethane vaginal cream for topical treatment cervical intraepitheliaa neoplasia (CIN)HHSN261201200025I
Ended Awarded Last action
- Contract number
- HHSN26100002
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $165,288
Award facts
- Contract value 100% obligated
- $165,288.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$554 | |
| Original award | $165,842 |
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 18, 2013.
How much is contract HHSN26100002 worth?
The government has obligated $165,288 on HHSN26100002.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN261201200025I, an indefinite delivery contract, on Preclinical Pharmacology and Toxicology Studies 2012-2014.
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award